Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of notice of board meeting published in the Free Press Journal (English Daily) and Navshakti (Marathi Daily) both edition dated 27th April, 2019, for intimation of Board Meeting scheduled to be held on 09th May, 2019 to consider audited financial results for the quarter/ financial year ended on 31.03.2019 as per Regulations 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on your records.
27-04-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Audited Financial Results For Quarter And Financial Year Ended 31St March, 2019

 MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2019 ,inter alia, to consider and approve We hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 9th May, 2019 at the registered office of the Company at Mumbai, inter-alia to consider and approve the following: 1.To consider and approve the Audited Financial Results/Statement of the company for the Quarter and Financial year ended 31st March, 2019; 2.Any other matters with the permission of the chair.
26-04-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Change in Directorate

 In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that Mr. Ajay Sawhney (DIN: 05132739) has submitted his resignation as an Independent Director of the Company with effect from 16th April, 2019 due to his personal reasons.
16-04-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Compliances- Certificate Under Regulation 40(9)/ 40(10) Of Securities And Exchange Board Of India(Listing Obligations And Disclosure Requirements)Regulations, 2015 For The Half Year Ended 31St March,2019.

 Please find enclosed herewith the Certificate under Regulation 40(9)/ 40(10)of Securities and Exchange Board of India(Listing Obligations & Disclosure Requirements) Regulations, 2015 for the half year ended 31st March, 2019 issued by CS Sandeep Gandhi, Practicing Company Secretary. Kindly take the same on your records.
12-04-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholding for the Period Ended March 31, 2019

 Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
09-04-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended March 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nikita BavishiDesignation :- Company Secretary and Compliance Officer
09-04-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances- Compliance Certificate For The Period Ended March, 2019

 With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance officer and Authorised Representative of Link Intime India Pvt Ltd (RTA) for the half year ended 31st March, 2019. Kindly take the same on your records.
09-04-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window

 Pursuant to the clarification received from National Stock Exchange of India Limited (NSE) dated 2nd April, 2019 vide Ref No: NSE/CML/2019/11 and BSE Limited (BSE) dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20 and in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, please note that the Trading Window for dealing in the securities of the Company will remain closed for all Directors, Officers, Designated Persons of the Company and their immediate relatives with immediate effect till the end of 48 hours after the Audited Financial Results for the quarter and year ended 31st March, 2019 are approved by the Board of Directors and filed with the Stock Exchanges.
04-04-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Kishoriju Trading & Investment Pvt Ltd
03-04-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading And Investment Pvt Ltd
30-03-2019
Next Page
Close

Let's Open Free Demat Account